Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression

Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression

Co-Investigator

Thomas Blue, Ph.D., Friends Research Institute

Co-Investigator

Ali Jalali, Ph.D., Weill Cornell Medical College

Co-Investigator

Raphael J. Landovitz, MD, MSc, University of California, Los Angeles

Funded By

National Institute on Drug Abuse

Grant Number

R01DA056287

Total Project Period

8/15/23 – 6/30/28